Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02054026 · ClinicalTrials.gov registry record · NA

Impact Evaluation of the Reducing the Risk Program

A NA study, sponsored by Mathematica Policy Research.

Completed
Registry status
NA
Development phase
2,220
Enrollment target

NCT02054026: Completed NA study, sponsored by Mathematica Policy Research.

NCT02054026 is a NA study that has completed, run by Mathematica Policy Research. The registered enrollment target is 2,220 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02054026, a NA study, has completed, sponsored by Mathematica Policy Research.

COMPLETED
Registry status
NA
Development phase
2,220 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of an eight-hour version of Reducing the Risk on outcomes such as sexual initiation, condom and contraceptive use, number of sexual partners, and pregnancy.

Interventions

  • BEHAVIORAL Reducing the Risk

Trial Details

FieldValue
Enrollment Target 2,220 participants
Start Date 2013-08
Est. Completion 2016-12
Phase NA
Mathematica Policy Research

29 total trials

What the finished NCT02054026 record still lists

NCT02054026 is an interventional study that assigns participants to a tested intervention. Its 2,220 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (58% higher).

The record links to 0 conditions, and to 1 intervention - of which Reducing the Risk is the first listed.

NCT02054026 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02054026 about?

NCT02054026 is a clinical study titled "Impact Evaluation of the Reducing the Risk Program". The purpose of this study is to evaluate the effectiveness of an eight-hour version of Reducing the Risk on outcomes such as sexual initiation, condom and contraceptive use, number of sexual partners, and pregnancy.

What is the current status of trial NCT02054026?

This trial is currently completed. It is a NA study. The enrollment target is 2,220 participants. The study started on 2013-08. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02054026?

The interventions under investigation include: Reducing the Risk (BEHAVIORAL).

Who is sponsoring clinical trial NCT02054026?

This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02054026's enrollment target sits among peer trials

2,220 48th of 2000 higher than 1,953 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06831929 · 2,232 participants · NA

    HPV Ends Here: Increasing Uptake of the HPV Vaccine

  • NCT06939803 · 2,236 participants · NA

    AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

  • NCT05654207 · 2,200 participants · NA

    WeCare: A System of Care for Black Youth

  • NCT06144554 · 2,200 participants

    Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02054026, the US trial registry maintained by the National Library of Medicine. NCT02054026 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.